How severe is CVE-2023-33365?

CVE-2023-33365 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2023-33365 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (50th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-33365?

CVE-2023-33365 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-33365?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-33365 published?

CVE-2023-33365 was published on 2023-08-03 and last updated on 2026-06-17.

CVE-2023-33365

CVE-2023-33365 is a high-severity vulnerability in Supremainc Biostar 2 with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Severity: High (CVSS 3.x base score 7.5)
EPSS exploit prediction: 1% (50th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-22
Affected product: Supremainc Biostar 2
Published: 2023-08-03
Last modified: 2026-06-17

Description

A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.

Frequently asked questions

What is CVE-2023-33365?: A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
How severe is CVE-2023-33365?: CVE-2023-33365 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2023-33365 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (50th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-33365?: CVE-2023-33365 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-33365?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-33365 published?: CVE-2023-33365 was published on 2023-08-03 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*

More vulnerabilities in Supremainc Biostar 2

CVE-2023-33366 — High (CVSS 8.8): A SQL injection vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows authenticated users to inject…
CVE-2023-33364 — High (CVSS 8.8): An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to…
CVE-2023-31923 — High (CVSS 8.8): Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an…
CVE-2022-38351 — High (CVSS 8.8): A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System…
CVE-2023-33363 — High (CVSS 7.5): An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to…
CVE-2020-15050 — High (CVSS 7.5): An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2. Remote attackers can read arbitrary…

All CVEs affecting Supremainc Biostar 2 →

Other CWE-22 (Path Traversal) vulnerabilities

CVE-2026-48282 — Critical (CVSS 10.0): ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Limitation of a Pathname to a Restricted…
CVE-2026-54917 — Critical (CVSS 10.0): SeaweedFS is a distributed storage system for object storage (S3), file systems, and Iceberg tables. Prior to 4.30, the…
CVE-2026-11429 — Critical (CVSS 10.0): Two endpoints in the Vault Service ScriptsController, shared by Altium Enterprise Server and Altium 365, accept file…
CVE-2026-34909 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit a Path Traversal vulnerability found in UniFi OS devices to…
CVE-2026-7411 — Critical (CVSS 10.0): In Eclipse BaSyx Java Server SDK versions prior to 2.0.0-milestone-10, inadequate path normalization in the Submodel…
CVE-2026-36767 — Critical (CVSS 10.0): A path traversal vulnerability in the /content/images/add endpoint of shopizer v3.2.5 allows attackers write arbitrary…

Browse all CWE-22 (Path Traversal) vulnerabilities →